Anti-VISTA/ VSIR/ B7-H5 monoclonal antibody
Anti-VISTA/ VSIR/ B7-H5 antibody for FACS & in-vivo assay
Go to VSIR/VSIR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T99704-Ab-1/ GM-Tg-hg-T99704-Ab-2 | Anti-Human VSIR monoclonal antibody | Human |
GM-Tg-rg-T99704-Ab-1/ GM-Tg-rg-T99704-Ab-2 | Anti-Rat VSIR monoclonal antibody | Rat |
GM-Tg-mg-T99704-Ab-1/ GM-Tg-mg-T99704-Ab-2 | Anti-Mouse VSIR monoclonal antibody | Mouse |
GM-Tg-cynog-T99704-Ab-1/ GM-Tg-cynog-T99704-Ab-2 | Anti-Cynomolgus/ Rhesus macaque VSIR monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T99704-Ab-1/ GM-Tg-felg-T99704-Ab-2 | Anti-Feline VSIR monoclonal antibody | Feline |
GM-Tg-cang-T99704-Ab-1/ GM-Tg-cang-T99704-Ab-2 | Anti-Canine VSIR monoclonal antibody | Canine |
GM-Tg-bovg-T99704-Ab-1/ GM-Tg-bovg-T99704-Ab-2 | Anti-Bovine VSIR monoclonal antibody | Bovine |
GM-Tg-equg-T99704-Ab-1/ GM-Tg-equg-T99704-Ab-2 | Anti-Equine VSIR monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T99704-Ab-1/ GM-Tg-hg-T99704-Ab-2; GM-Tg-rg-T99704-Ab-1/ GM-Tg-rg-T99704-Ab-2; GM-Tg-mg-T99704-Ab-1/ GM-Tg-mg-T99704-Ab-2; GM-Tg-cynog-T99704-Ab-1/ GM-Tg-cynog-T99704-Ab-2; GM-Tg-felg-T99704-Ab-1/ GM-Tg-felg-T99704-Ab-2; GM-Tg-cang-T99704-Ab-1/ GM-Tg-cang-T99704-Ab-2; GM-Tg-bovg-T99704-Ab-1/ GM-Tg-bovg-T99704-Ab-2; GM-Tg-equg-T99704-Ab-1/ GM-Tg-equg-T99704-Ab-2 |
Products Name | Anti-VSIR monoclonal antibody |
Format | mab |
Target Name | VSIR |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-VSIR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Biosimilar | GMP-Bios-ab-406 | Pre-Made Onvatilimab biosimilar, Whole mAb, Anti-VSIR Antibody: Anti-B7-H5/B7H5/C10orf54/DD1alpha/Dies1/GI24/PD-1H/PP2135/SISP1/VISTA therapeutic antibody |
Target Antigen | Products Developing | Multi-species VISTA/ VSIR/ B7-H5 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLV000879 | human VSIR Lentivirus plasmid |
ORF Viral Vector | vGMLV000880 | human VSIR Lentivirus particle |
ORF Viral Vector | pGMLV000880 | human VSIR Lentivirus plasmid |
ORF Viral Vector | pGMLP004294 | human VSIR Lentivirus plasmid |
ORF Viral Vector | vGMLP004294 | human VSIR Lentivirus particle |
ORF Viral Vector | vGMLV000879 | human VSIR Lentivirus particle |
ORF Viral Vector | pGMLPm003507 | mouse Vsir Lentivirus plasmid |
ORF Viral Vector | vGMLPm003507 | mouse Vsir Lentivirus particle |
Target information
Target ID | GM-T99704 |
Target Name | VSIR |
Gene ID | 64115,74048,690899,709595,106558705,101096355,783068,102149832 |
Gene Symbol and Synonyms | 4632428N05Rik,B7-H5,B7H5,C10orf54,C1H10orf54,C28H10orf54,C4H10orf54,C9H10orf54,C9orf54,CD2H10orf54,DD1alpha,Dies1,GI24,PD-1H,PP2135,SISP1,VISTA,VSIR |
Uniprot Accession | Q9H7M9 |
Uniprot Entry Name | VISTA_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, INN Index |
Disease | N/A |
Gene Ensembl | ENSG00000107738 |
Target Classification | Checkpoint-Immuno Oncology |
The target: VSIR, gene name: VSIR, also named as B7-H5, B7H5, C10orf54, DD1alpha, GI24, PD-1H, PP2135, SISP1, VISTA. Enables endopeptidase activator activity; enzyme binding activity; and identical protein binding activity. Involved in several processes, including negative regulation of cytokine production; positive regulation of macromolecule metabolic process; and regulation of T cell activation. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.